Transcranial direct current stimulation (tDCS) in depression induces structural plasticity.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 02 2023
Historique:
received: 05 10 2022
accepted: 10 02 2023
entrez: 21 2 2023
pubmed: 22 2 2023
medline: 25 2 2023
Statut: epublish

Résumé

Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique involving administration of well-tolerated electrical current to the brain through scalp electrodes. TDCS may improve symptoms in neuropsychiatric disorders, but mixed results from recent clinical trials underscore the need to demonstrate that tDCS can modulate clinically relevant brain systems over time in patients. Here, we analyzed longitudinal structural MRI data from a randomized, double-blind, parallel-design clinical trial in depression (NCT03556124, N = 59) to investigate whether serial tDCS individually targeted to the left dorso-lateral prefrontal cortex (DLPFC) can induce neurostructural changes. Significant (FWEc p < 0.05) treatment-related gray matter changes were observed with active high-definition (HD) tDCS relative to sham tDCS within the left DLPFC stimulation target. No changes were observed with active conventional tDCS. A follow-up analysis within individual treatment groups revealed significant gray matter increases with active HD-tDCS in brain regions functionally connected with the stimulation target, including the bilateral DLPFC, bilateral posterior cingulate cortex, subgenual anterior cingulate cortex, and the right hippocampus, thalamus and left caudate brain regions. Integrity of blinding was verified, no significant differences in stimulation-related discomfort were observed between treatment groups, and tDCS treatments were not augmented by any other adjunct treatments. Overall, these results demonstrate that serial HD-tDCS leads to neurostructural changes at a predetermined brain target in depression and suggest that such plasticity effects may propagate over brain networks.

Identifiants

pubmed: 36801903
doi: 10.1038/s41598-023-29792-6
pii: 10.1038/s41598-023-29792-6
pmc: PMC9938111
doi:

Banques de données

ClinicalTrials.gov
['NCT03556124']

Types de publication

Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2841

Subventions

Organisme : NIMH NIH HHS
ID : K99 MH128572
Pays : United States
Organisme : NIMH NIH HHS
ID : R61/R33 MH110526
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Neuroimage. 2015 Feb 1;106:189-97
pubmed: 25482268
Quant Imaging Med Surg. 2020 Jan;10(1):257-268
pubmed: 31956547
J Neurosci Res. 2018 Aug;96(8):1367-1379
pubmed: 29876962
Transl Psychiatry. 2014 Nov 18;4:e483
pubmed: 25405780
CNS Neurosci Ther. 2018 Nov;24(11):994-1003
pubmed: 29508560
Neuropsychopharmacology. 2009 Apr;34(5):1255-62
pubmed: 19145228
J Affect Disord. 2012 Apr;138(1-2):9-18
pubmed: 21511342
Brain Stimul. 2014 Nov-Dec;7(6):813-6
pubmed: 25442152
Mol Psychiatry. 2020 Feb;25(2):397-407
pubmed: 31455860
Front Neurosci. 2020 Apr 21;14:374
pubmed: 32372913
Front Syst Neurosci. 2016 Dec 27;10:104
pubmed: 28082874
Brain Stimul. 2018 Sep - Oct;11(5):1008-1023
pubmed: 29929771
Biol Psychiatry. 2016 Feb 15;79(4):282-92
pubmed: 25842202
Brain Stimul. 2018 Jan - Feb;11(1):125-133
pubmed: 29111077
J Neural Eng. 2021 Oct 11;18(5):
pubmed: 34555822
Neuroimage. 2018 Dec;183:972-984
pubmed: 30261308
Am J Psychiatry. 2012 Jul;169(7):719-24
pubmed: 22581236
Psychiatry Clin Neurosci. 2017 Nov;71(11):747-758
pubmed: 28631869
Biol Psychiatry. 2022 Aug 1;92(3):193-203
pubmed: 35120710
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4367-75
pubmed: 25267639
Biol Psychiatry. 2020 Mar 1;87(5):451-461
pubmed: 31561859
Int Rev Psychiatry. 2017 Apr;29(2):146-167
pubmed: 28523976
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):11-6
pubmed: 22001316
N Engl J Med. 2017 Jun 29;376(26):2523-2533
pubmed: 28657871
Clin Neurophysiol. 2016 Feb;127(2):1031-1048
pubmed: 26652115
BMC Psychiatry. 2019 Jun 11;19(1):180
pubmed: 31185966
CNS Spectr. 2008 Aug;13(8):663-81
pubmed: 18704022
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
J Neural Eng. 2011 Dec;8(6):066017
pubmed: 22086257
Biol Psychiatry. 2016 Feb 15;79(4):264-5
pubmed: 26796876
Biol Psychiatry. 2018 Oct 15;84(8):574-581
pubmed: 30006199
Clin Neurophysiol. 2016 Nov;127(11):3425-3454
pubmed: 27693941
Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):405-15
pubmed: 21442687
Sci Rep. 2017 Aug 23;7(1):9222
pubmed: 28835651
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):170-175
pubmed: 27815324
Eur Arch Psychiatry Clin Neurosci. 2021 Feb;271(1):39-47
pubmed: 32385741
J Physiol. 2000 Sep 15;527 Pt 3:633-9
pubmed: 10990547
Front Cell Neurosci. 2016 Aug 08;10:188
pubmed: 27551261
Ann N Y Acad Sci. 2012 Mar;1251:E1-24
pubmed: 23025352
J ECT. 2010 Sep;26(3):159-74
pubmed: 20805726
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Cereb Cortex. 1995 Jul-Aug;5(4):323-37
pubmed: 7580125
Br J Psychiatry. 1995 Jul;167(1):99-103
pubmed: 7551619
Neurobiol Dis. 2013 Apr;52:4-11
pubmed: 23477309
Focus (Am Psychiatr Publ). 2019 Jan;17(1):18-29
pubmed: 31975955
Transl Psychiatry. 2021 Feb 24;11(1):138
pubmed: 33627624
Nat Commun. 2018 Feb 2;9(1):483
pubmed: 29396478
Neuroimage. 2014 Jan 15;85 Pt 3:895-908
pubmed: 23933040

Auteurs

Mayank A Jog (MA)

Department of Neurology, University of California Los Angeles (UCLA), Los Angeles, CA, 90095, USA. mayankjog@gmail.com.

Cole Anderson (C)

Diagnostic Imaging Sciences Center, University of Washington, Seattle, WA, 98195, USA.

Antoni Kubicki (A)

Department of Neurology, University of California Los Angeles (UCLA), Los Angeles, CA, 90095, USA.

Michael Boucher (M)

Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, 90095, USA.

Amber Leaver (A)

Department of Radiology, Northwestern University, Evanston, IL, 60208, USA.

Gerhard Hellemann (G)

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Marco Iacoboni (M)

Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, 90095, USA.

Roger Woods (R)

Department of Neurology, University of California Los Angeles (UCLA), Los Angeles, CA, 90095, USA.
Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, 90095, USA.

Katherine Narr (K)

Department of Neurology, University of California Los Angeles (UCLA), Los Angeles, CA, 90095, USA.
Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, 90095, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH